drugset / Trial / NCT00691912
Therapy of Metastatic Breast Cancer With Paclitaxel and Liposomal Doxorubicin
NaSingle-groupOpen-labelTreatment
Summary
Today metastatic breast cancer is regarded as cureless. The treatment is palliative in intent and the goals of treatment include improvement of quality of life and if possible prolongation of life. Treatment in metastatic cancer will usually involve hormone therapy and/or chemotherapy. Weekly application of chemotherapeutical drugs may lead to less drug concentrations in healthy tissue and therefore toxicities maý be reduced.
Timeline
- Start
- 2006-12
- Primary completion
- 2013-12
- Completion
- 2013-12
Outcome
Outcome not reported
Stopped: “Study was stopped due because recrutation.was much slower as anticipated.”
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Doxorubicin | Other / unclassified | 20 mg/m2 | — |
| Subject | Paclitaxel | Small molecule | 80 mg/m2 | — |